HERMES PHARMA Obtains Prestigious GMP Certification from Russian Authorities

Pullach, Germany, January 16, 2018 — HERMES PHARMA, the expert in user-friendly oral dosage forms, successfully completed the Good Manufacturing Practices (GMP) inspection of its production facilities by Russian authorities. The German plant in Wolfratshausen, as well as the production facility in Wolfsberg, Austria, are now both authorized to manufacture medicinal products for the Russian market. The certification covers the manufacturing of several dosage forms and products.

User-friendly dosage forms such as instant drinks, orally disintegrating granules, lozenges, effervescent and chewable tablets represent a rapidly growing opportunity in the pharmaceuticals market, especially for patients who find swallowing tablets difficult. These dosage forms are also gaining traction in Russia as companies seek to better meet the needs of patients, while diversifying their product portfolio, strengthening their brands and extending product lifecycles.

More than 7,000 tons of material is processed and two billion effervescent and chewable tablets, lozenges, instant drinks and orally disintegrating granules are manufactured annually in HERMES PHARMA’s production plants. All operations, such as weighing, blending, granulating, tableting and packaging, take place in highly-automated systems. Rigorous quality assurance and control ensure compliance with GMP, regulatory demands and client specifications.

Dr Thomas Hein, Senior Vice President Commercial and Regulatory Affairs at HERMES PHARMA, said: “For a contract development & manufacturing organization (CDMO) like HERMES PHARMA, the successful inspection through the Russian authorities is extremely important. It does not only reflect our long-standing commitment to producing high quality products under stringent GMP conditions. It also marks a significant milestone as we are now able to fully support our customers wishing to sell their medicinal products manufactured by us into the Russian market.”

HERMES PHARMA is the expert in the development and production of user-friendly oral dosage forms, including effervescent and chewable tablets, lozenges, orally disintegrating granules and instant drinks. The company provides custom solutions along the entire pharmaceutical value chain – from the development of new product ideas and formulations to production and regulatory support. For more than 40 years, leading pharmaceutical and healthcare companies around the globe work with HERMES PHARMA to expand their product lines and grow their brands. Further information is available at

Press Contacts:
Eva Hildebrandt
Lucy Turpin Communications
+49 89 417761-14

Eva Tietz
Manager Marketing & PR